Recently, the expression of FUN14 domain-containing protein 1 was positively correlated with breast cancer metastasis and the Ca2+/NFATC1/BMI1 axis, suggesting that inhibition of this protein could represent a therapeutic target for breast cancer (Wu et al., 2019). This evidence concerns the gene FUNDC1 and breast carcinoma.